Collagen-based injectable drug delivery system and its use

Overview

Information

Number
5807581
Application
08/537073
Filing date
09/29/1995
Issue date
09/15/1998
Inventor(s)
Joel S. Rosenblatt, Richard A. Berg
US Classification
424/422; 424/424; 424/426; 424/484; 424/485; 424/486; 424/487; 604/890.1
View at USPTO

Citations

Cellex Biosciences (3)
University of Medicine and Dentistry of New Jersey (3)
Cohesion Technologies (3)
ALLERGAN (2)
COLLAGEN (1)
Research (1)
Slovenska vedecko-technicka spolocnost, Dom techniky (1)
Astra Lakemedel Aktiebolag (1)
Atrix Laboratories (1)
Stanford University (1)
ANGIODEVICE INTERNATIONAL (1)
VISION 2000 TECHNOLOGIES (1)
NATTERMANN & CIE (1)
Professional Dietetics S.r.l. (1)
MDV Technologies (1)

Abstract

Abstract

Drugs are delivered in a sustained manner from an in vivo depot which is formed from a collagen-based injectable composition. The injectable composition is fluid when injected but undergoes crosslinking in situ to form a crosslinked collagen matrix which encloses the drug to be released. The composition also includes a flexible chain polymer which is similarly charged to the precrosslinked collagen. This flexible chain polymer is enclosed in the matrix as well when the matrix forms and alters the effective porosity of the matrix. The drug diffuses out of the matrix at a rate which depends upon the matrix's effective porosity.

Assignees with Similar Patents

Referenced by

forsight vision4 (48)
conextions (20)
mimedx group (20)
Incept (16)
Devicor Medical Products (11)
University of Utah (9)
encapsule medical (6)
University of Pittsburgh (5)
The Johns Hopkins University (4)
shanghai qisheng biological preparation (3)
Covidien (2)
Integra Lifesciences I, (2)
l a m pharmaceutical (2)
Northwestern University (2)
Tohoku University (2)
dermelle (1)
shanghai haohai biological technology (1)
Purdue Research Foundation (1)
CAROLL, ROBERT G. (1)
Tapic International Co. (1)
SHIMIZU, YASUHIKO (1)
SUMITOMO PHARMA CO., LTD. (1)

Tech Analysis

Class Subclass Type Reference Factor Citation Factor Strength Grant time Early grant (%)
424 422 Emerging Average Seminal Medium Average 54.3
424 424 Stable Average Average Medium Average 61.1
424 426 Emerging Average Seminal Medium Average 54.3
424 484 Emerging Average Seminal Medium Average 55.2
424 485 Stable Sustaining Seminal Medium Average 65.1
424 486 Emerging Average Seminal Medium Average 57.2
424 487 Stable Average Seminal Medium Average 53.7
604 890.1 Emerging Average Seminal Medium High Average 52.2